From Name:
From Email:
To Name:
To Email:

Optional Message:


Telaprevir- and boceprevir-based triple therapy for hepatitis C in liver transplant recipients with advanced recurrent disease: A multicenter study

from Transplantation (login required)

Antiviral treatment with sustained virologic response improves survival in liver transplant recipients and is especially relevant to patients with advanced recurrent hepatitis C virus. Researchers assessed the safety and efficacy of protease inhibitor–based triple therapy in patients with recurrent advanced fibrosis and cholestatic hepatitis. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063